Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erectile disorders: the reality].

M W Hengeveld1, W L Gianotten

  • 1Erasmus Universitair Medisch Centrum, afd. Psychiatrie, Postbus 2040, 3000 CA Rotterdam. hengeveld@psyd.azr.nl

Nederlands Tijdschrift Voor Geneeskunde
|August 10, 2001
PubMed
Summary

Erectile disorder affects 3-10% of men aged 40-79. Current treatments like sildenafil and surgery have limitations, with many patients dissatisfied or discontinuing therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Psychiatrist's language].

Tijdschrift voor psychiatrie·2023
Same author

[Psychiatric diagnosis: personalised by definition].

Tijdschrift voor psychiatrie·2018
Same author

[Reaction on 'Guideline psychiatric diagnostics 2015; strong positioning and some loose ends'].

Tijdschrift voor psychiatrie·2016
Same author

[Diagnosis should not be confused with classification in psychiatry].

Tijdschrift voor psychiatrie·2014
Same author

An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation.

International journal of psychiatry in clinical practice·2014
Same author

[The DSM: background and translation].

Tijdschrift voor psychiatrie·2014

Area of Science:

  • Urology
  • Andrology
  • Psychiatry

Context:

  • Prevalence estimates for erectile dysfunction (ED) vary widely, often exceeding 50% when grouped with erectile disorder (EDD).
  • Two Dutch population studies focusing specifically on EDD in men aged 40-79 reported more realistic prevalence rates of 3-10%.

Purpose:

  • To critically evaluate the prevalence and management of erectile disorder.
  • To discuss the implications of pharmacotherapy and surgical interventions for EDD.
  • To examine current reimbursement policies for EDD treatments in the Netherlands.

Summary:

  • The Leiden Impotence Screening Test can identify somatic causes, but physician-led diagnosis is preferred.
  • Sildenafil and surgical options like intracavernosal injections and prosthesis implantation have shown limited long-term patient satisfaction.
  • High discontinuation rates for sildenafil and dissatisfaction with surgical options highlight treatment challenges.

Impact:

  • Re-evaluation of EDD prevalence based on specific diagnostic criteria is crucial.
  • The study questions the long-term efficacy and patient satisfaction with current EDD treatments.
  • The findings advocate for a review of healthcare reimbursement policies for cost-effective EDD therapies, including psychosexual therapy.

Related Experiment Videos